Bone Marrow Transplant in Turkey: Treatment Guide

This guide explains how bone marrow transplant, also called hematopoietic stem cell transplant, is planned and delivered for international patients in Turkey. You will learn about candidate evaluation, transplant options, hospital stay, recovery, travel logistics, cost factors and follow-up support at Acibadem International.

What is this treatment?

A bone marrow transplant is a treatment that replaces or restores the body’s blood-forming stem cells. These cells normally live in the bone marrow and produce red blood cells, white blood cells and platelets. The medical term is hematopoietic stem cell transplant, because stem cells can be collected from bone marrow, circulating blood or, in selected cases, umbilical cord blood.

The transplant itself is usually given through a vein, similar to a blood transfusion. Before this step, you receive a carefully planned conditioning treatment, which may include chemotherapy and sometimes other medicines or radiotherapy, depending on your disease and transplant type. The aim is to make space for healthy stem cells, treat remaining disease and help the new cells settle in the marrow.

There are two main categories. In an autologous transplant, your own stem cells are collected and returned after intensive therapy. In an allogeneic transplant, stem cells come from a donor whose tissue type is compatible with yours. Acibadem International supports patients through the detailed evaluation, donor planning, inpatient transplant period and follow-up coordination required for this complex treatment.

When is it recommended?

Bone marrow transplant may be recommended when a specialist team believes it offers a meaningful treatment option for a serious blood, immune or marrow condition. It is used in selected patients with diseases such as leukemia, lymphoma, multiple myeloma, aplastic anemia, myelodysplastic syndromes, certain inherited immune deficiencies, some metabolic diseases and other rare disorders. The exact indication varies widely between adults and children.

Recommendation depends not only on the name of the disease, but also on its stage, genetic and molecular features, response to previous treatment, general health and available alternatives. For some patients, transplant is part of first-line treatment; for others, it is considered after relapse or when standard therapies are unlikely to provide durable control.

The decision is always individualized. A hematology or pediatric hematology team reviews your medical records, pathology reports, imaging, laboratory results and previous therapies before advising whether transplant is suitable. In some cases, additional tests are needed to clarify disease status or to compare transplant with other treatment options.

Who is a good candidate?

A good candidate is someone whose condition is likely to benefit from transplant and whose body can safely tolerate the preparation, inpatient care and recovery period. Doctors evaluate heart, lung, kidney and liver function, current infection status, performance level, nutrition, previous treatments and emotional readiness. Age alone is not the only factor; overall fitness and disease biology are very important.

For allogeneic transplant, donor suitability is also central. A matched sibling, matched unrelated donor, partially matched family donor or cord blood source may be considered depending on availability and urgency. The transplant team also evaluates blood group, tissue typing, donor health and the risks and benefits of each donor option.

You may not be ready for transplant if there is an uncontrolled infection, unstable organ function, active disease that needs further treatment first or a temporary medical issue that increases risk. This does not always mean transplant is impossible. It may mean that treatment must be optimized before moving forward, and your team will explain the safest path.

Treatment options

Autologous stem cell transplant uses your own previously collected stem cells. It is commonly considered in selected patients with multiple myeloma, lymphoma and some other conditions. Because the cells are your own, there is no graft-versus-host disease; however, it is still an intensive treatment and requires careful infection prevention while blood counts recover.

Allogeneic transplant uses stem cells from a donor. It may be recommended for certain leukemias, marrow failure syndromes, myelodysplastic syndromes, inherited immune disorders and other diseases where a new blood and immune system may be beneficial. Donor sources may include a matched sibling, matched unrelated donor, haploidentical family donor or cord blood, depending on your situation.

Conditioning regimens may be myeloablative, meaning more intensive, or reduced-intensity, meaning adjusted for patients who may not tolerate full-intensity therapy. The stem cell source may be peripheral blood, bone marrow or cord blood. Supportive care, infection prevention, transfusion support, nutrition care and post-transplant medicines are also part of the treatment plan, not separate extras.

For children and adults, the most appropriate approach can differ. At Acibadem, multidisciplinary teams may include hematologists, pediatric hematologists, infectious disease specialists, intensive care specialists, transfusion medicine teams, nurses, pharmacists, dietitians and international patient coordinators to help align the transplant plan with your medical and practical needs.

Online evaluation before travel

International patients often begin with an online medical evaluation before deciding to travel. This helps the medical team understand your diagnosis, urgency, previous treatments and whether a transplant consultation in Turkey is appropriate. It also helps you receive realistic information about expected length of stay, caregiver needs and which documents are required.

You will usually be asked to share pathology reports, bone marrow biopsy results, flow cytometry, cytogenetic or molecular testing, imaging, discharge summaries, chemotherapy records, current medications and recent blood tests. If a donor has already been tested, HLA typing and donor health information are also important. Clear copies in English are helpful; if they are in another language, your coordinator can advise what should be translated.

An online review is not the same as final medical clearance. The transplant plan may change after in-person examination, updated tests and review of original pathology or imaging. Still, this first step gives you a safer, more organized way to plan travel and avoid unnecessary delays after arrival.

Before the treatment

Before transplant, you will have a detailed pre-transplant assessment. This may include blood tests, infection screening, heart and lung evaluations, kidney and liver function tests, dental review, imaging, disease reassessment and consultations with relevant specialists. The aim is to reduce preventable risks and confirm that the planned transplant remains appropriate.

If an autologous transplant is planned, stem cells must be collected in advance. This usually involves medicines that help stem cells move into the blood, followed by a collection procedure called apheresis. If an allogeneic transplant is planned, donor testing, eligibility checks and collection scheduling are coordinated carefully so the donor cells are available at the right time.

You may need a central venous catheter for chemotherapy, transfusions, blood tests and the stem cell infusion. Your team will explain infection precautions, nutrition advice, fertility considerations where relevant, vaccination history, medication changes and what your companion should expect. It is important to tell your doctors about all medicines, supplements, allergies and previous complications from anesthesia or chemotherapy.

What happens during the treatment

The treatment begins with admission to a specialized transplant unit. Conditioning therapy is given first according to your protocol. During this time, nurses and doctors monitor you closely, manage nausea or mouth discomfort if it occurs, support hydration and nutrition, and check blood tests frequently.

The stem cell infusion usually takes place through your central line. Many patients are surprised that the transplant day itself can feel less dramatic than the preparation period. The cells travel through the bloodstream to the bone marrow, where they begin the process of engraftment, meaning they start producing new blood cells.

After the infusion, there is a waiting period while blood counts are low. You may need antibiotics, antiviral or antifungal medicines, transfusions, pain control, mouth care, nutritional support and protective precautions. For allogeneic transplant, you may also receive medicines to reduce the risk of graft-versus-host disease, a condition where donor immune cells can react against the body.

Hospital stay and discharge

Hospital stay after bone marrow transplant is usually measured in weeks rather than days. The exact duration depends on the type of transplant, how quickly your blood counts recover, whether you develop fever or other complications, and how stable you are with eating, drinking and walking. Your room environment, visitor rules and hygiene precautions are designed to reduce infection risk while your immune system is vulnerable.

Discharge is considered when your team is confident that you are clinically stable, your blood counts are recovering or safely manageable, you can take necessary medicines, and you have a clear follow-up plan. You and your companion will receive instructions about temperature checks, medication schedules, food safety, catheter care if needed and when to contact the hospital.

Many international patients remain near the hospital after discharge for early outpatient controls before being cleared to travel home. This period is important because some issues appear after leaving the inpatient unit. Acibadem International coordinators help align appointments, interpreter support and practical arrangements so you can focus on recovery.

Recovery timeline

Recovery after bone marrow transplant is gradual and varies from person to person. Early milestones include engraftment, infection control, improved appetite and safe discharge. Longer-term milestones include immune rebuilding, medication tapering where appropriate, vaccination planning and disease response monitoring.

The timeline below is a general guide only. Your transplant type, diagnosis, age, donor source, complications and previous treatments can make recovery faster or slower. Always follow the schedule and restrictions given by your own transplant physician.

Timeframe	What to expect
First 24 hours	Stem cell infusion is completed and you are monitored for reactions, vital signs, fluid balance and symptoms related to conditioning treatment.
First week	Blood counts are usually low. You may need transfusions, infection prevention, mouth care, nutrition support and close monitoring for fever or side effects.
Weeks 2-4	Engraftment may occur during this period, though timing varies. Doctors assess blood count recovery, infections, organ function and readiness for discharge or outpatient care.
Months 1-3	Energy and appetite may improve gradually. Follow-up remains frequent, and infection precautions, medication adherence and monitoring for graft-versus-host disease may be needed.
Final result	Disease response and immune recovery are assessed over months and sometimes longer. Some patients require ongoing therapy, vaccinations, monitoring or additional interventions.

Feeling tired, needing rest and having changes in taste or appetite can be part of recovery. The most important point is not to compare your progress with another patient’s timeline; your team will interpret your tests and symptoms in the context of your own condition.

What to avoid after treatment

After transplant, your immune system needs time to recover. You may be advised to avoid crowded indoor spaces, contact with people who are unwell, unapproved raw foods, unsafe water sources, gardening soil, construction dust and certain pets or animal waste during the highest-risk period. These restrictions are usually adjusted as your immune system improves.

You should not start vitamins, herbal products, supplements or over-the-counter medicines without asking your transplant team. Some products can interact with anti-infection medicines, immune-suppressing medicines or liver and kidney function. Alcohol, smoking and recreational drugs can also interfere with recovery and should be discussed honestly with your doctor.

Avoid delaying medical contact if you feel unwell. After transplant, symptoms that seem minor can need early assessment. Also avoid non-urgent travel, dental work, live vaccines or strenuous exercise until your physician confirms they are safe for you.

Risks and possible complications

Bone marrow transplant is a complex treatment, and risks differ according to transplant type, disease, conditioning regimen and personal health. Possible complications include infections, bleeding due to low platelets, anemia, mouth sores, nausea, diarrhea, fatigue, liver or kidney strain, lung problems and reactions to medicines or transfusions. Supportive care is a major part of transplant medicine because many side effects can be prevented, detected early or managed.

In allogeneic transplant, graft-versus-host disease can occur when donor immune cells affect organs such as the skin, liver or digestive tract. It can be mild or more serious and may occur early or later. Your team will use preventive medicines when appropriate and monitor symptoms closely.

Other possible concerns include delayed engraftment, graft failure, infertility, hormonal changes, cataracts, bone health changes, relapse of the original disease or need for further treatment. These possibilities can feel overwhelming, but they are exactly why transplant is performed in a specialized unit with experienced monitoring. Your doctors will explain your individual risk profile before treatment, without making guarantees.

Warning signs: when to contact a doctor

After transplant, early communication is one of the best ways to stay safe. Your discharge plan will include contact numbers and instructions for urgent and non-urgent concerns. If you are unsure whether a symptom matters, it is better to ask your transplant team.

• Fever, chills or feeling suddenly unwell
• Shortness of breath, chest pain or persistent cough
• Bleeding that does not stop, black stools, blood in urine or unusual bruising
• Severe or persistent vomiting, diarrhea or abdominal pain
• New or spreading rash, yellowing of the eyes or skin, or severe itching
• Confusion, severe headache, fainting, seizure or marked drowsiness
• Pain, redness, swelling or discharge around a catheter site
• Inability to take prescribed medicines or keep fluids down
• Reduced urination, sudden swelling or rapid weight change
• Any symptom that is rapidly worsening or feels concerning to you

If you have returned home, contact your local emergency service when urgent care is needed, and inform the Acibadem team as soon as possible. Keeping your transplant summary and medication list with you helps local doctors understand your situation quickly.

Results and expectations

The goals of bone marrow transplant vary. For some patients, the aim is long-term disease control or remission. For others, it is to restore marrow function, correct an immune problem or create a new blood-forming system after intensive therapy. Your doctor will explain what success means in your specific diagnosis and how it will be measured.

Results are followed through blood tests, bone marrow examinations, imaging, donor chimerism tests for allogeneic transplant and disease-specific markers. Some early results can be seen within weeks, such as blood count recovery, while deeper disease response and immune recovery may require months or longer.

It is important to have realistic expectations. Not every transplant achieves the desired outcome, and some patients need additional treatment, donor lymphocyte infusion, maintenance therapy or, rarely, another transplant. Your team will discuss these possibilities in a balanced way and tailor follow-up to your needs.

International patient travel planning

Travel planning for bone marrow transplant requires more preparation than many elective treatments. You may need to stay in Turkey for the inpatient transplant period and for early outpatient monitoring afterward. Your companion plays an important role in helping with communication, medicines, meals, transport and emotional support, especially after discharge.

Before travel, confirm passport validity, visa requirements, insurance documents, medical records, donor-related documents if applicable and the expected length of stay. You should also discuss fitness to fly, infection precautions during travel and whether any urgent treatment is needed before departure from your home country.

After transplant, travel clearance depends on your clinical condition, blood counts, infection status, medication needs and follow-up arrangements. Acibadem International can assist with interpreter services, airport transfers, accommodation guidance near the hospital and coordination with your home physician for remote follow-up.

Cost and package information

The cost of bone marrow transplant depends on many factors, including the diagnosis, transplant type, donor source, conditioning regimen, length of hospital stay, laboratory monitoring, blood product needs, medications, infection management, intensive care needs if required and follow-up schedule. Allogeneic transplant can involve additional donor search, donor testing, collection and compatibility processes.

A typical treatment quotation may include medical consultations, pre-transplant tests, inpatient transplant care, standard nursing care, stem cell infusion, routine monitoring, certain medications and planned follow-up visits during the defined package period. The exact inclusions must be reviewed in writing because transplant care can change based on your clinical course.

Items that may not be included can include flights, visas, accommodation outside the hospital, companion expenses, non-standard tests, unexpected complications, prolonged hospitalization, special donor search costs, some medicines after discharge and care provided after returning home. Acibadem International provides individualized quotations after medical review, without using one-size-fits-all pricing for this complex treatment.

Why choose Acibadem

Bone marrow transplant requires a coordinated hospital environment, specialized laboratory support, experienced nursing and rapid access to multiple specialties. Acibadem’s JCI-accredited hospitals provide structured quality and safety processes, transplant-focused units and multidisciplinary teams for adult and pediatric patients. This is especially important for international patients who need clear planning before, during and after travel.

Your care may involve hematology, pediatric hematology, infectious diseases, radiology, pathology, transfusion medicine, intensive care, pharmacy, nutrition and rehabilitation support. The goal is not only to perform the transplant, but also to manage the weeks of monitoring and supportive care that surround it.

Acibadem International also helps with the practical side of treatment in another country. Interpreter support, medical appointment coordination, airport transfers, accommodation guidance and remote follow-up communication can make the process more understandable for you and your family.

Medical review and disclaimer

This guide has been reviewed by the Acibadem International medical team. It is designed to give general information about bone marrow transplant in Turkey and to help international patients prepare informed questions for their doctors.

The information here does not replace a personal consultation, physical examination or review of your medical records by a qualified physician. Bone marrow transplant suitability depends on diagnosis, disease status, organ function, donor availability, previous treatment and many individual factors.

No medical outcome can be guaranteed. Your final treatment plan, expected benefits, risks, recovery timeline and travel clearance must be confirmed by your transplant physician after a complete evaluation.